SCICLONE PHARMACEUTICALS INTERNATIONAL (CAYMAN) DEVELOPMENT LIMITED
🇰🇾Cayman Islands
- Country
- 🇰🇾Cayman Islands
- Ownership
- Private
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sciclone.com/
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study
Phase 1
- Conditions
- Advanced Solid TumorNon-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2016-08-31
- Last Posted Date
- 2018-04-25
- Target Recruit Count
- 75
- Registration Number
- NCT02884479
- Locations
- 🇨🇳
Changhua Christian Hospital, Changhua County, Taiwan
🇨🇳China Medical University & Hospital, Taichung, Taiwan
🇨🇳National Cheng Kung University Hospital, Tainan City, Taiwan
News
No news found